Ventas (NYSE: VTR) is the perennial number two of senior housing: the same demographic tailwind as Welltower, a similar SHOP-led model, and a valuation that has never commanded Welltower’s premium, which is precisely the appeal for investors who want the supercycle at a discount.
| Ventas (VTR) Snapshot | |
|---|---|
| Share Price (delayed) | $92.06 +1.54% |
| Market Cap | $44.8B |
| Annualized Dividend | $2.00 (Quarterly) |
| Dividend Yield | 2.17% |
| Credit Rating | BBB+ (S&P) |
| Sector | Healthcare ยท Senior Housing & Research |
Market data updates automatically several times daily. Last price refresh: Jul 13, 2026.
Business Model and 2026 Setup
Ventas guides 2026 normalized FFO to $3.83 at the midpoint, 8% growth, driven by significant SHOP NOI growth and accretive senior housing acquisitions, partially offset by the expiration of non-cash Brookdale rent and higher interest expense. The portfolio spans senior housing operating communities, outpatient medical, and research/lab assets, a broader (and slightly messier) mix than pure senior housing peers. The strategy is unambiguous: recycle everything else into more senior housing while the demand wave builds.
Dividend Safety Analysis
Ventas cut its dividend in the pandemic (the scar every senior housing investor remembers) and has kept the payout conservative since, resuming growth as FFO recovers. Current coverage is comfortable with a BBB+ balance sheet. The payout math is fine; the memory is the discount.
The Honest Risk Section
Execution gap. Ventas has structurally trailed Welltower on SHOP margins and per-share growth for years, and the 2026 Brookdale lease transition removes a rent stream while conversion executes. Interest expense is a headwind against the growth. This is the value-priced way to own the demographic story, and it is value-priced for reasons.
Frequently Asked Questions
How does Ventas compare to Welltower?
Same demographic thesis, lower valuation, historically slower execution: 8% guided FFO growth versus Welltower’s 20%+, at a materially cheaper multiple with a higher yield.
Is Ventas’s dividend safe?
Yes at current coverage with a BBB+ balance sheet, though the 2020 pandemic cut explains why the market demands a wider margin of safety here.
Analysis based on 2026 company guidance. Live market data updates automatically. Independent research, not investment advice.